ETFdb Realtime Rating & Analyst Report for XPH
XPH is a passive ETF that seeks to replicate the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is an equal weighted market cap index.
| ETFdb Category | Expense Ratio | Inception Date | Issuer | Structure | YTD Return * |
|---|---|---|---|---|---|
| Health & Biotech Equities | 0.35% | 2006-06-19 | State Street | ETF | +9.02% |
* As of 05-24-2012
XPH Realtime Rating: By Metric
| Metric | Metric Realtime Rating | A+ Metric Rated ETF |
|---|---|---|
| Liquidity | B+ | XLV |
| Expenses | B+ | XLV |
| Performance |  |
|
| Volatility | |
|
| Dividend | |
|
| Concentration | |
|
The first adjacent table gives investors an individual Realtime Rating for XPH on several different metrics, including liquidity, expenses, performance, volatility, dividend, and concentration of holdings. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities ETFdb Category with the highest Metric Realtime Rating for each individual field.
XPH Realtime Rating: Overall
| ETFdb Rating Type | Overall Rating | A+ Overall Rated ETF |
|---|---|---|
| Realtime Rating (Overall) | |
|
The second table shows the overall Realtime Rating for XPH, as well as the A+ Overall Rated ETF in XPH's Category. To view information on how the ETFdb Realtime Ratings work, click here.
ETFdb Analyst Report for XPH
This ETF is one of several options for investors looking to establish exposure to the U.S. pharmaceutical industry, a sub-sector of the health care space that can post big returns during periods of consolidation or as a result of advancements in medicine. Given this narrow focus, XPH probably doesn...
Pro Membership Required to Continue Reading
To view the entire ETFdb Realtime Rating, you must be an ETFdb Pro member. To see all that is included in the ETFdb Realtime Rating, see the free previews of ten of the most popular ETFs: SPY, GLD, VWO, EFA, EEM, IVV, QQQ, TIP, VTI, LQD . Please login or begin your 7-day free trial to continue reading. There are several benefits to becoming an ETFdb Pro member today:
Get valuable insight from our analysts in the ETFdb Category reports, with in-depth breakdown every ETF niche, large or small.- Get portfolio guidance on nearly every possible investor scenario and include detailed information on risk profiles, asset correlation, portfolio management, and more.
- Get access to our premium monthly newsletter ETF Edge.
- Gain access to premium research reports covering popular sectors of the ETF industry.
- Read in-depth monthly Q&A's with our Senior Analyst Michael Johnston.
- Use the ETFdb Pro Screener to screen ETFs according to your own customized parameters, then download the results in Microsoft Excel format.
- Get 100% access to the ETF Head-To-Head Comparison Tool, a resource that shows how more than 1,100 ETFs stack up against the competition in terms of performance, holdings, and technical strength.
Begin Your Free 7-Day Trial Now - or - Read more about ETFdb Pro
